A
Apollomics Inc
NASDAQ:APLM
Apollomics Inc
NASDAQ:APLM
Price:
22
USD
1.89%
Market Closed
Market Cap:
$48.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apollomics Inc
NASDAQ:APLM
|
US |
|
F
|
First Advantage Corp
NASDAQ:FA
|
US |
Intrinsic Value
Not Available for APLM
There is not enough data to reliably calculate the intrinsic value for Apollomics Inc.
Do our valuations actually work? See backtest results .
Alternatives to APLM
Fundamental Analysis
What Apollomics Does
Apollomics is a biotechnology company focused on developing medicines for cancer. It works on drug candidates that are meant to block the signals tumors use to grow, spread, and resist treatment, especially in hard-to-treat cancers. The company is not a large drug seller; it is a research-and-development business built around finding, testing, and advancing new oncology treatments.
- Headquarters
- United States of America US
- Employees
- 14
- IPO date
- Nov 26, 2021
Efficiency
Earnings Waterfall
Apollomics Inc
Apollomics Inc